COMMUNICATION
News & Press Release
Total 122
-
22Neurobiogen, 'New Target' for Alzheimer's Dementia Development...Apply for Phase 1 clinical IND this
DATE : 2021-10-05
VIEW : 2720
-
21Neurobiogen "Dental effects of dementia drugs...Investment attraction drive."
DATE : 2021-09-15
VIEW : 2770
-
20Change the paradigm of treating Alzheimer's...Clinical Applications within the Year.
DATE : 2021-09-09
VIEW : 2750
-
19'Unknown Territories.' Dementia."New drugs will be developed in 20 years."
DATE : 2021-08-02
VIEW : 2777
-
18Dementia, kidney disease, glaucoma...domestic companies challenged by incurable diseases.
DATE : 2021-06-01
VIEW : 2679
-
17Lee Seung-hwan, a professor at Seoul National University Hospital, said, "With a new treatment mecha
DATE : 2021-05-09
VIEW : 2726
-
16Neurobiogen, New Drug Candidate Material 'KDS2010(SEREMABI)' U.S. Material Patent Registry.
DATE : 2021-04-14
VIEW : 2670
-
15Neurobiogen to Develop 'Cerematovi', a treatment for Alzheimer's Dementia.
DATE : 2021-03-25
VIEW : 2619
-
14Neurobiogen, a high-profile CNS professional venture...Technology Transfer Propulsion.
DATE : 2021-03-25
VIEW : 2633
-
13Han Seol-hee, a professor of neurology at Konkuk University, said, "Alzheimer's disease is a lifesty
DATE : 2021-03-03
VIEW : 2765
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved